A recent study published in Brain Communications has shed light on how traumatic brain injuries, such as those experienced in ...

Notably, microglia spatially associated with amyloid plaques exhibited increased expression of TREM2 and ApoE compared to ...

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...

A new study published in Alzheimer’s & Dementia has found that while Alzheimer’s disease is more common in women, men tend to experience a quicker decline in brain health and cognitive abilities once ...

But in just the past year and a half, two anti-amyloid drugs—lecanemab (Leqembi) and donanemab (Kisunla)—that can slow the progression of early Alzheimer’s disease have been approved in the US.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently ...

In a study of biomarkers in Alzheimer’s dementia, plasma p-tau217 had greater agreement with CSF and amyloid-PET biomarker ...

A new study from Lund University suggests that traumatic brain injury (TBI) may contribute to Alzheimer’s disease by altering ...

Northwestern researchers made progress on new biochemical possibilities this week, in both the human brain and everyday ...

A groundbreaking peer-reviewed Thought Leaders Invited Review article in Brain Medicine (Genomic Press, New York ...

Long-term NSAID use reduces dementia risk, particularly in those without the APOE-ε4 gene, highlighting the importance of ...